Literature DB >> 19460405

Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats.

Christian G Reich1, Michael E Taylor, Margaret M McCarthy.   

Abstract

Chronic unpredictable mild stress (CMS), an animal model of depression, downregulates hippocampal CB1 receptors in adult male rats. Given that endocannabinoids are implicated in modulating stress and anxiety and that women are vulnerable to stress-related disorders, we tested the effects of CMS on both female and male rats. Gonadectomized (gndx) and gonadally intact male and female rats were exposed to a three-week chronic stress protocol. Following CMS, CB1 receptor and fatty-acid-amide-hydrolase (FAAH) expression levels in the hippocampus were assessed by western blot analysis. CMS reliably produced a downregulation of CB1 receptors ( approximately 50%) in the hippocampus of both gndx and intact males. This effect was more robust in the dorsal than in the ventral hippocampus. Conversely, CMS produced an upregulation of CB1 receptors ( approximately 150%) in the hippocampus of both gndx and intact females. This upregulation was only observed in the dorsal hippocampus of female animals. CMS produced an upregulation of FAAH levels in both male and female animals. In non-stress control animals, males were observed to have higher CB1 levels than females, but no differences in FAAH were found. These findings suggest that the endocannabinoid (eCB) system is preferentially organized in male and female animals to respond differentially to chronic stress. These sex differences in the eCB system may help development of novel treatments for stress and depression that are designed specifically for women and men.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460405      PMCID: PMC2747651          DOI: 10.1016/j.bbr.2009.05.013

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  36 in total

1.  Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress.

Authors:  Matthew N Hill; Sachin Patel; Erica J Carrier; David J Rademacher; Brandi K Ormerod; Cecilia J Hillard; Boris B Gorzalka
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

2.  Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.

Authors:  R J Rodgers; P M Evans; A Murphy
Journal:  Behav Pharmacol       Date:  2005-09       Impact factor: 2.293

3.  Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats.

Authors:  Angela J Grippo; Nicole R Sullivan; Katerina J Damjanoska; James W Crane; Gonzalo A Carrasco; Ju Shi; Zhuo Chen; Francisca Garcia; Nancy A Muma; Louis D Van de Kar
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 4.  When is a sex difference not a sex difference?

Authors:  Margaret M McCarthy; Anne T M Konkle
Journal:  Front Neuroendocrinol       Date:  2005-09       Impact factor: 8.606

Review 5.  Endocannabinoid system and stress and anxiety responses.

Authors:  M P Viveros; Eva M Marco; Sandra E File
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

6.  Sex differences in Fos protein expression in the neonatal rat brain.

Authors:  K M Olesen; A P Auger
Journal:  J Neuroendocrinol       Date:  2005-04       Impact factor: 3.627

Review 7.  Gender differences in depression: implications for treatment.

Authors:  S G Kornstein
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 8.  Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS.

Authors:  Paul Willner
Journal:  Neuropsychobiology       Date:  2005-07-19       Impact factor: 2.328

Review 9.  Gender differences in the genetic epidemiology of major depression.

Authors:  K S Kendler
Journal:  J Gend Specif Med       Date:  1998 Oct-Nov

10.  Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.

Authors:  Guy Griebel; Jeanne Stemmelin; Bernard Scatton
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

View more
  81 in total

1.  Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice.

Authors:  N P Bowles; M N Hill; S M Bhagat; I N Karatsoreos; C J Hillard; B S McEwen
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

Review 2.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

Review 3.  Neurobiology of chronic mild stress: parallels to major depression.

Authors:  Matthew N Hill; Kim G C Hellemans; Pamela Verma; Boris B Gorzalka; Joanne Weinberg
Journal:  Neurosci Biobehav Rev       Date:  2012-07-07       Impact factor: 8.989

4.  Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Behav Brain Res       Date:  2015-12-09       Impact factor: 3.332

5.  Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion.

Authors:  M López-Gallardo; A B López-Rodríguez; Á Llorente-Berzal; D Rotllant; K Mackie; A Armario; R Nadal; M-P Viveros
Journal:  Neuroscience       Date:  2011-10-06       Impact factor: 3.590

Review 6.  Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.

Authors:  Diana Dow-Edwards; Ashley Frank; Dean Wade; Jeremy Weedon; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2016-09-12       Impact factor: 3.763

7.  Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.

Authors:  Matthew N Hill; Cecilia J Hillard; Bruce S McEwen
Journal:  Cereb Cortex       Date:  2011-01-24       Impact factor: 5.357

Review 8.  Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors:  Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal:  Psychoneuroendocrinology       Date:  2014-10-22       Impact factor: 4.905

Review 9.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

10.  Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis.

Authors:  Susanne A Wolf; Anika Bick-Sander; Klaus Fabel; Perla Leal-Galicia; Svantje Tauber; Gerardo Ramirez-Rodriguez; Anke Müller; Andre Melnik; Tim P Waltinger; Oliver Ullrich; Gerd Kempermann
Journal:  Cell Commun Signal       Date:  2010-06-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.